by adminTorusBrand | Mar 7, 2017 | Axim Biotechnologies, Press Releases
NEW YORK, March 7, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first-ever publicly traded cannabis company in the United States, announced today that its major investment company AXIM® Biotechnologies, Inc. (AXIM® Biotech) (AXIM) has enrolled 40 patients and...
by adminTorusBrand | Mar 1, 2017 | Axim Biotechnologies, HempMeds Brasil, HempMeds Mexico, Kannalife Sciences, Press Releases
SAN DIEGO, March 1, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, is reassuring customers, shareholders, and the public that the company’s operations in the federally legal hemp cannabidiol...
by adminTorusBrand | Mar 1, 2017 | Axim Biotechnologies, HempMeds Brasil, HempMeds Mexico, Kannalife Sciences, Press Releases
SAN DIEGO, March 1, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, is reassuring customers, shareholders, and the public that the company’s operations in the federally legal hemp cannabidiol...
by adminTorusBrand | Feb 14, 2017 | Axim Biotechnologies, Company News, HempMeds, HempMeds Brasil, HempMeds Mexico, Kannaway, Media Coverage
Medical Marijuana, Inc. VP of Operations Blake Schroeder and Andrew Hard, CEO of CMW Media, sat down with Drew Schlosberg of the San Diego Union-Tribune Community Spotlight late last week to discuss the cannabis industry and Medical Marijuana, Inc.’s role as a proven...
by adminTorusBrand | Feb 14, 2017 | Axim Biotechnologies, Company News, HempMeds, HempMeds Brasil, HempMeds Mexico, Kannaway, Media Coverage
Medical Marijuana, Inc. VP of Operations Blake Schroeder and Andrew Hard, CEO of CMW Media, sat down with Drew Schlosberg of the San Diego Union-Tribune Community Spotlight late last week to discuss the cannabis industry and Medical Marijuana, Inc.’s role as a proven...
by adminTorusBrand | Feb 3, 2017 | Axim Biotechnologies, Company News, Media Coverage, Scientific Research
[vc_row][vc_column][vc_column_text]CanChew® Plus and AXIM® Biotechnologies were part of a news segment this week on CBS New York regarding the company’s ongoing clinical trials for the use of its patented CanChew® Plus CBD gum for the treatment of irritable bowel...